Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Do patients on extended courses of systemic corticosteroids benefit from oral bisphosphonate therapy to prevent steroid-induced osteoporosis?

Weinstein, Sara D., PharmD, BCPS; Copenhaver, Ardis M., MS, PharmD, BCPS; Koenig, Marianne E., PharmD, BCPS

doi: 10.1097/EBP.0000000000000266
HELPDESK ANSWERS
Buy

UPMC St. Margaret, Pittsburgh, PA

The authors declare no conflicts of interest.

© Copyright 2019 Family Physicians Inquiries Network, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website